Daily Ards Research Analysis
Analyzed 12 papers and selected 3 impactful papers.
Summary
Two mechanistic studies advance ARDS/ALI pathophysiology by identifying neutrophil-derived itaconate as an extracellular epigenetic cue in alveolar macrophages and revealing myeloid Becn1 as a gatekeeper of pulmonary–intestinal immune homeostasis. A nationwide study delineates humidifier lung as a distinct hypersensitivity pneumonitis subtype with ARDS-like clusters, refining differential diagnosis in acute respiratory failure.
Research Themes
- Innate immune metabolism and epigenetic control in ALI/ARDS
- Autophagy and the gut–lung axis in lung injury
- Differential diagnosis of ARDS mimics using multimodal phenotyping
Selected Articles
1. Neutrophil-derived itaconate facilitates tiered pulmonary inflammation via Kdm5b-associated epigenetic remodeling in alveolar macrophages.
Using multi-omics and biochemical approaches, the study identifies neutrophil-derived itaconate as an extracellular cue that orchestrates sequential immune cell infiltration in ALI/ARDS. Itaconate reprograms alveolar macrophage chromatin via Kdm5b at Il6/Ccl5/Cxcl10 promoters, linking innate immunometabolism to epigenetic control of lung inflammation.
Impact: Revealing an extracellular metabolite–epigenetic axis (itaconate–Kdm5b) in alveolar macrophages advances mechanistic understanding and nominates a druggable pathway for ARDS.
Clinical Implications: Although preclinical, targeting the itaconate–KDM5B axis may modulate chemokine-driven leukocyte recruitment in ALI/ARDS. Related transcripts (IL6/CCL5/CXCL10) could support biomarker development for inflammatory staging.
Key Findings
- Neutrophil-derived extracellular itaconate correlates with sequential infiltration of neutrophils, T cells, and monocytes in ALI/ARDS models.
- Itaconate promotes Kdm5b-associated epigenetic remodeling at Il6, Ccl5, and Cxcl10 promoters in alveolar macrophages.
- Multi-omics and biochemical data converge on an immunometabolic–epigenetic mechanism of leukocyte recruitment.
Methodological Strengths
- Integrated multi-omics with biochemical validation to link metabolite signaling to chromatin regulation
- Cell type–specific mechanistic focus on alveolar macrophages and defined promoter targets
Limitations
- Preclinical models may not capture ARDS heterogeneity in humans
- Extent of human validation and in vivo pharmacologic modulation of the itaconate–Kdm5b axis is limited in the available text
Future Directions: Quantify airway/alveolar itaconate in ARDS patients, test KDM5B modulators in vivo, and assess the axis as a stage-specific therapeutic target and biomarker.
Acute lung injury (ALI) and its severe form, acute respiratory distress syndrome (ARDS), present a substantial clinical burden, magnified by conditions such as COVID-19. While these conditions provide a model for exploring complex inflammatory processes, the environmental factors coordinating these responses remain poorly understood. Here, we employ comprehensive multi-omics and biochemical analyses and identify neutrophil-derived itaconate as an extracellular factor associated with sequential immune cell infiltration, including neutrophils, T cells, and monocytes. Mechanistically, extracellular itaconate metabolically facilitates Kdm5b-associated epigenetic changes at the Il6, Ccl5, and Cxcl10 gene promoters in alveolar macrophages, which are important for immune cell recruitment. Consistent with this, Mrp8-Cre Acod1
2. Myeloid-specific Becn1 deficiency elicits spontaneous pulmonary injury and exacerbates acute lung injury.
Myeloid Becn1 deletion in mice causes spontaneous lung injury and intensifies LPS-induced ALI, alongside intestinal barrier defects and microbiome dysbiosis. The work positions autophagy (Becn1) as a central regulator of lung inflammation and gut–lung crosstalk relevant to ARDS pathogenesis.
Impact: By linking myeloid autophagy to both pulmonary injury and gut–lung axis disruption, this study identifies a mechanistic lever that could be targeted to prevent hyperinflammation in ALI/ARDS.
Clinical Implications: Autophagy modulation may mitigate ALI severity and restore gut–lung homeostasis; BECN1-related pathways merit exploration as pharmacologic targets and for patient stratification.
Key Findings
- Myeloid Becn1 deficiency alone induces spontaneous lung injury with increased alveolar–capillary permeability and inflammatory infiltration.
- Upon LPS challenge, Becn1-deficient mice exhibit exacerbated pulmonary pathology and amplified cytokine storm.
- Becn1 cKO mice show intestinal barrier dysfunction and microbiota dysbiosis (e.g., depleted Actinobacteria, expanded Alistipes), implicating gut–lung crosstalk in ALI severity.
Methodological Strengths
- Conditional myeloid-specific knockout model with multi-compartment readouts (lung, intestine, microbiome)
- Comprehensive profiling including BALF cytokines, bulk RNA-seq, histology, and 16S rRNA sequencing
Limitations
- Mouse models (including LPS-induced ALI) may not fully recapitulate human ARDS heterogeneity
- Lack of interventional rescue experiments directly restoring Becn1 function in vivo
Future Directions: Test pharmacologic autophagy modulators, define causal microbiome contributors, and evaluate BECN1 pathway biomarkers in human ARDS cohorts.
BACKGROUND: Acute lung injury (ALI) and its severe phenotype, acute respiratory distress syndrome (ARDS), represent devastating and highly lethal respiratory disorders. Hallmarked by unrestrained pulmonary inflammation predominantly driven by myeloid cells, these conditions ultimately culminate in profound disruption of the alveolar-capillary barrier. The reciprocal crosstalk between autophagy and inflammation and its molecular underpinnings in ALI pathogenesis remain incompletely defined. METHODS: The role of myeloid Becn1 in maintaining pulmonary homeostasis and modulating susceptibility to lipopolysaccharide (LPS)-induced ALI was defined, and the potential link between intestinal barrier integrity, gut microbiota, and ALI severity was further interrogated. The expression of BECN1 in bronchoalveolar lavage fluid (BALF) cells from patients with ARDS and in lung tissues of mice with LPS-induced ALI was detected by western blot and immunofluorescence respectively. Myeloid cell-specific Becn1 conditional knockout (cKO) mice were generated. Parallel analyses were performed in both steady-state and LPS-challenged mice, including quantitative lung histopathological analysis, inflammatory cytokine profiling of BALF, bulk RNA sequencing of lung tissue, histological assessment of intestinal architecture and intestinal tight junction integrity, and 16S rRNA gene sequencing of fecal microbiota. RESULTS: Myeloid Becn1 deficiency alone was sufficient to disrupt pulmonary homeostasis, leading to spontaneous lung injury characterized by increased alveolar-capillary permeability, inflammatory cell infiltration, and aberrant activation of immune-inflammatory pathways. When challenged with LPS, these pre-existing inflammatory priming effects translated to exacerbated pulmonary pathology and exaggerated cytokine storm. Beyond the lung, Becn1 cKO mice developed spontaneous intestinal barrier dysfunction and gut microbiota dysbiosis at steady state, including blunted intestinal villi, reduced goblet cells, impaired tight junction integrity, increased mast cell infiltration, and a characteristic microbial shift with depleted Actinobacteria and expanded Alistipes. All these intestinal and microbial perturbations were likely further amplified by LPS challenge, consistent with a potential association between intestinal-microbial dysregulation and exacerbated pulmonary injury. CONCLUSIONS: Myeloid Becn1 governs pulmonary-intestinal immune homeostasis, and its deficiency drives spontaneous lung injury, hyperinflammation, impaired gut-lung crosstalk, and exacerbated acute lung injury, establishing myeloid Becn1 as a critical determinant of acute lung injury severity.
3. Humidifier lung and summer-type hypersensitivity pneumonitis in Japan: a nationwide retrospective observational study of clinical, radiological and pathological features.
In a nationwide, multi-center retrospective study, 430 HFL and 784 SHP cases were identified. HFL showed higher CRP but lower KL-6/SP-D, more airspace consolidation on CT, and greater intra-alveolar organization with fewer granulomas; cluster analysis revealed an ARDS-like HFL phenotype with normal KL-6 that complicates diagnosis.
Impact: Defines distinct HFL phenotypes including an ARDS-like cluster, improving differentiation of ARDS mimics and guiding appropriate management.
Clinical Implications: In acute respiratory failure with ARDS-like imaging but normal KL-6, consider HFL; targeted environmental history and antigen avoidance may avert misdiagnosis and unnecessary ARDS-specific interventions.
Key Findings
- Identified 430 HFL and 784 SHP cases nationwide with rising HFL incidence, notably during the COVID-19 pandemic.
- HFL had higher CRP but lower KL-6 and SP-D than SHP (all p<0.0001), with more airspace consolidation and fewer centrilobular GGO nodules on CT.
- Histology showed more intra-alveolar organization and fewer epithelioid granulomas in HFL; cluster analysis revealed an ARDS-like/OP-like HFL cluster with normal KL-6.
Methodological Strengths
- Large, nationwide, multi-center dataset with comparative clinical–radiologic–pathologic analysis
- Use of cluster analysis to uncover phenotypic subgroups relevant to differential diagnosis
Limitations
- Retrospective design with potential for misclassification and missing data
- Limited external generalizability beyond Japan and heterogeneous diagnostic workups across centers
Future Directions: Prospective validation of diagnostic algorithms integrating CT patterns and biomarkers, and evaluation of outcomes with early antigen avoidance versus standard ARDS pathways.
BACKGROUND: Humidifier lung (HFL) is a rare subtype of hypersensitivity pneumonitis (HP); understanding of the clinical, radiological and pathological characteristics is limited. To clarify the phenotype of HFL, this study compared HFL with the more established summer-type HP (SHP). METHODS: This nationwide survey of patients with HFL was conducted in 214 participating facilities across Japan from January 2011 to December 2021. Clinical, radiological and histopathological findings were comparatively evaluated between patients diagnosed with HFL and those with SHP. RESULTS: Overall, 430 HFL and 784 SHP cases were identified, with an increasing trend over time and a marked rise in HFL during the COVID-19 pandemic. Detailed data from 278 HFL and 220 SHP cases showed that HFL patients were older and predominantly male. HFL exhibited higher serum C-reactive protein levels but lower Krebs von den Lungen-6 (KL-6) and surfactant protein D levels than SHP (all p<0.0001).Chest CT in both cohorts included ground-glass opacities and mosaic attenuation; centrilobular ground-glass nodules were less frequent in HFL, which more frequently showed airspace consolidation.Histopathology demonstrated alveolitis in both with more intra-alveolar organisation and fewer epithelioid cell granulomas in HFL.Cluster analysis identified an HFL cluster with either Acute Respiratory Distress Syndrome (ARDS)-like or organising pneumonia-like high-resolution CT findings and normal KL-6, hence diagnosis can be challenging. Conversely, the major cluster of SHP showed typical CT features and elevated KL-6. CONCLUSIONS: HFL exhibits distinct clinical, radiological and pathological characteristics compared to SHP, suggesting a unique subtype. This holds relevance for diagnostic accuracy and improved patient outcomes.